Virios Therapeutics, Inc.·4

Jan 12, 7:43 PM ET

Gendreau Roger Michael 4

4 · Virios Therapeutics, Inc. · Filed Jan 12, 2021

Insider Transaction Report

Form 4
Period: 2021-01-01
Gendreau Roger Michael
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2021-01-01+41,73441,734 total
    Exercise: $7.51Exp: 2031-01-01Common Stock (41,734 underlying)
Footnotes (1)
  • [F1]Stock option granted pursuant to the reporting person's employment agreement. The stock option vests one-third on January 1, 2022 and 1/24th monthly thereafter.

Documents

1 file
  • 4
    tm212264d2_4.xmlPrimary

    OWNERSHIP DOCUMENT